Simplex Trading’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,136
Closed -$29K 8714
2025
Q3
$29K Sell
1,136
-27,135
-96% -$629K ﹤0.01% 7005
2025
Q2
$575K Buy
28,271
+26,233
+1,287% +$511K ﹤0.01% 3350
2025
Q1
$36K Buy
+2,038
New +$45.5K ﹤0.01% 6087
2024
Q3
Sell
-8,600
Closed -$328K 8595
2024
Q2
$318K Sell
8,600
-15,501
-64% -$585K ﹤0.01% 4154
2024
Q1
$1.01M Buy
+24,101
New +$990K ﹤0.01% 3109
2023
Q3
Sell
-491
Closed -$15.4K 8768
2023
Q2
$16K Buy
+491
New +$16.5K ﹤0.01% 6963
2023
Q1
Sell
-12,102
Closed -$522K 9119
2022
Q4
$539K Buy
12,102
+3,186
+36% +$114K ﹤0.01% 3086
2022
Q3
$250K Sell
8,916
-7,630
-46% -$234K ﹤0.01% 4318
2022
Q2
$446K Buy
16,546
+4,294
+35% +$125K ﹤0.01% 3574
2022
Q1
$417K Sell
12,252
-738
-6% -$23.6K ﹤0.01% 4076
2021
Q4
$501K Sell
12,990
-23,921
-65% -$1.04M ﹤0.01% 3810
2021
Q3
$1.27M Sell
36,911
-200
-0.5% -$9.38K ﹤0.01% 2753
2021
Q2
$1.24M Buy
37,111
+34,565
+1,358% +$949K ﹤0.01% 2810
2021
Q1
$52K Sell
2,546
-25,598
-91% -$588K ﹤0.01% 6558
2020
Q4
$493K Buy
28,144
+11,082
+65% +$199K ﹤0.01% 3449
2020
Q3
$253K Sell
17,062
-45,530
-73% -$533K ﹤0.01% 3811
2020
Q2
$813K Buy
+62,592
New +$277K ﹤0.01% 2342
2020
Q1
Sell
-13,705
Closed -$31K 7651
2019
Q4
$30K Buy
13,705
+9,522
+228% +$22.1K ﹤0.01% 5646
2019
Q3
$8K Sell
4,183
-1,582
-27% -$3.66K ﹤0.01% 6358
2019
Q2
$15K Buy
5,765
+4,937
+596% +$16.8K ﹤0.01% 5827
2019
Q1
$4K Buy
+828
New +$4.36K ﹤0.01% 6542
2018
Q1
Sell
-122
Closed -$4.73K 6209
2017
Q4
$5K Buy
+122
New +$5.23K ﹤0.01% 4470
2017
Q3
Sell
-961
Closed -$36K 5959
2017
Q2
$35K Buy
+961
New +$42.5K ﹤0.01% 2714
2016
Q2
Sell
-885
Closed -$56.2K 5854
2016
Q1
$50K Buy
885
+602
+213% +$67.7K ﹤0.01% 1954
2015
Q4
$66K Sell
283
-29
-9% -$6.32K 0.01% 1689
2015
Q3
$49K Buy
312
+26
+9% +$7.36K ﹤0.01% 2015
2015
Q2
$108K Sell
286
-1,133
-80% -$450K 0.01% 1160
2015
Q1
$593K Buy
1,419
+668
+89% +$239K 0.07% 266
2014
Q4
$206K Buy
+751
New +$187K 0.03% 589

Other funds holding CLDX